๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Low-dose dexamethasone suppression test in Japanese patients with Parkinson's disease

โœ Scribed by T. Kawamura; M. Kinoshita; Y. Iwasaki; H. Nemoto


Publisher
Springer
Year
1987
Tongue
English
Weight
124 KB
Volume
234
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Dexamethasone suppression test in patien
โœ Dr. Vladimir S. Kostiฤ‡; Nadeลพda ฤŒoviฤkoviฤ‡-ล terniฤ‡; Ljiljana Beslaฤ‡-Bumbaลกireviฤ‡ ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 337 KB

## Abstract The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divide

Levodopa treatment does not affect low-d
โœ Svenja Happe; Tobias Tings; Kathrin Helmschmied; Karin Neubert; Wolfgang Wuttke; ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB

## Abstract Challenge with lowโ€dose apomorphine causes a significant rise in growth hormone (GH) in patients with Parkinson's disease (PD) compared to controls and patients with multiple system atrophy (MSA) who have not previously received dopaminergic treatment. To date, it has not been demonstra

Camptocormia in Japanese patients with P
โœ Morinobu Seki; Kazushi Takahashi; Atsuo Koto; Ban Mihara; Yoko Morita; Kazuo Iso ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 264 KB ๐Ÿ‘ 1 views

## Abstract ## Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. ## Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the prev